AUDREY FORD: Open Payments
NPI 1376773697 · PALM HARBOR, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$610 in 28 payments from 14 companies in 2025. Trend: 2023 $480 · 2024 $539 · 2025 $610
Food & beverage: $610
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $152 |
| ABBVIE INC. | 3 | $75 |
| Botanix SB Inc | 3 | $61 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $58 |
| Almirall LLC | 2 | $46 |
| Amgen Inc. | 2 | $37 |
| Galderma Laboratories, L.P. | 2 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| UCB, Inc. | 1 | $24 |
Products named: COSENTYX, SOFDRA, SKYRIZI, OTEZLA, BOTOX, NEMLUVIO, DUPIXENT, Seysara.
Industry payments across FL — which companies pay providers there.
